Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Meningitis in the Neonate.

David W. Kimberlin1

  • 1Division of Pediatric Infectious Diseases, The University of Alabama at Birmingham, 1600 Seventh Avenue, South, Suite 616, Birmingham, AL 35233, USA. dkimberlin@peds.uab.edu

Current Treatment Options in Neurology
|April 5, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Visual Impairment and Driving in Older Adults: A Narrative Review.

Current treatment options in neurology·2026
Same journal

Non-Cognitive Symptoms in Alzheimer's Disease and Their Likely Impact on Patient Outcomes. A Scoping Review.

Current treatment options in neurology·2026
Same journal

Update on the Treatment of Autonomic Disorders.

Current treatment options in neurology·2025
Same journal

Primary Progressive Aphasia Treatment: Current Treatment Options in Neurology Article Topic: Management of Primary Progressive Aphasia.

Current treatment options in neurology·2025
Same journal

Emerging Principles for Treating Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD).

Current treatment options in neurology·2025
Same journal

Diagnosis and Management of Progressive Corticobasal Syndrome.

Current treatment options in neurology·2025

Neonatal meningitis is primarily caused by Group B Streptococcus and E. coli. Early empiric antibiotic therapy, tailored by cerebrospinal fluid culture results, is crucial for treating this serious infection in newborns.

Area of Science:

  • Neonatal Medicine
  • Infectious Diseases
  • Pediatric Neurology

Background:

  • Neonatal meningitis is a critical infection predominantly caused by Group B beta-hemolytic streptococci and Escherichia coli.
  • Common pathogens in older children, such as Haemophilus influenzae type B, are rare causes of meningitis in neonates.
  • Clinical signs of neonatal meningitis are often nonspecific, including temperature instability, lethargy, and feeding difficulties.

Purpose of the Study:

  • To outline the common pathogens, clinical manifestations, and recommended treatment strategies for neonatal meningitis.
  • To emphasize the importance of timely and appropriate antimicrobial therapy based on causative agents.
  • To highlight the need for ongoing monitoring of hearing and development in affected infants.

Main Methods:

Related Experiment Videos

  • Review of current literature and clinical guidelines for neonatal meningitis management.
  • Analysis of common bacterial pathogens and their susceptibility patterns.
  • Description of recommended empiric and targeted antibiotic regimens.
  • Guidelines for follow-up examinations, including cerebrospinal fluid analysis and neuroimaging.

Main Results:

  • Group B Streptococcus and E. coli are the leading causes of neonatal meningitis.
  • Initial empiric treatment typically involves ampicillin with gentamicin or cefotaxime.
  • Therapy is adjusted based on cerebrospinal fluid culture and susceptibility testing.
  • Treatment duration varies by pathogen, generally 14-21 days or longer for gram-negative bacilli.

Conclusions:

  • Prompt and accurate diagnosis and treatment are essential for improving outcomes in neonatal meningitis.
  • Tailoring antibiotic therapy to identified pathogens and considering patient-specific factors (e.g., prematurity, catheter use) is critical.
  • Long-term monitoring of hearing and neurodevelopment is vital for all infants treated for neonatal meningitis.